Can Aging Be Reversed? What Longevity Science Actually Shows

Can aging actually be reversed — or is most of “anti-aging” still hype? In this solo FAQ episode, Dr. Hillary Lin breaks down what longevity science can a…

Published November 7, 2024The Longevity Show

This is a Friday FAQs episode, and the question at its centre is the one the whole field is built on: can aging actually be reversed, or is it hype? Dr. Lin's answer separates three things people routinely collapse together — the experimental science, which is real and genuinely exciting; the consumer products built on top of it, which are mostly ahead of their evidence; and lifestyle, which she is unusually strict about. She will say lifestyle slows aging and reverses specific damage. She will not say it reverses aging, because she does not think the evidence supports it.

The bottleneck she keeps returning to is measurement. Horvath's 2013 epigenetic clock was a milestone precisely because before it there was no way to judge whether an anti-aging therapy was doing anything. The field now has DNA methylation clocks refined by machine learning, telomere length, glycan-based inflammaging measures, and newer approaches like quantifying 'biological noise' across organs. Her verdict is that no single test is especially good yet — and until one is, the whole intervention question stays partly unanswerable.

From there the episode walks the actual mechanisms: cellular reprogramming via the Yamanaka factors, chemical reprogramming cocktails, partial and intermittent reprogramming; then senolytics — dasatinib, quercetin, fisetin, navitoclax — with a careful accounting of what is human evidence and what is still mouse. Then supplements, where she rates omega-3s well-supported, CoQ10 reasonable, collagen mostly a digestibility argument, resveratrol out of favour, and NAD+ precursors substantially over-hyped. It closes on listener questions about green tea and kidney function, and about foods that speed up metabolism — where her answer is to reframe the question entirely.

Before you watch

Dr. Lin's account of why she left conventional practice is unusually direct: 10-to-15 minute visits in what she calls insurance-gated healthcare, treating small problems for extremely complicated patients, and a caseload large enough that details get lost. She describes moral outrage at how people were being treated and says building her own practice is harder and pays less reliably, but that it is how she believes medicine should be done — moving from what she calls a 'don't die' model to actual health care.
Biological age and chronological age come apart, and they come apart unevenly across the body — heart, liver, skin and eyes can each be aging at different rates. Steve Horvath's 2013 epigenetic clock, built on DNA methylation patterns, was the first credible way to quantify this, and the current generation of clocks are machine-learning algorithms complex enough that you cannot compute them by hand.
Telomeres are not a simple longer-is-better story, and Dr. Lin is careful about it. They shorten with each division and short telomeres are linked to cardiovascular disease and weakened immunity — but excessively long telomeres produce effectively immortal cells and tumour risk, and you want some cells to die on schedule. Research into extending telomeres has produced genuinely mixed results, and her read is that the relationship is not linear enough for extension to be a strategy on its own.
Cellular reprogramming is the most striking mechanism and the furthest from use. Shinya Yamanaka's 2006 discovery — that Oct4, Sox2, Klf4 and c-Myc can return mature cells to a pluripotent state — won the Nobel Prize in 2012, and subsequent work has reset the epigenetic clock, reduced inflammation and restored regenerative capacity in aged human cells. The critical refinement is that you want partial reprogramming, applied intermittently, not a full reset: in mice engineered to age prematurely, that approach improved tissue function and extended lifespan. Dr. Lin's assessment is that this is promising and still a long way from humans.
Chemical reprogramming is the more tractable cousin — cocktails of small molecules that mimic the Yamanaka effect and reset gene expression without altering DNA. Because it introduces a chemical rather than performing genetic reprogramming, Dr. Lin frames it as potentially safer and more accessible, though still experimental.
Senolytics clear senescent 'zombie' cells, which accumulate with age and secrete inflammatory signals that damage surrounding tissue. The four with the most evidence — dasatinib, quercetin, fisetin and navitoclax — all work by selectively inducing apoptosis in cells that have developed ways to evade normal cell death. The specificity matters: dasatinib is particularly effective against human preadipocytes, quercetin against senescent human endothelial cells and mouse bone-marrow-derived mesenchymal stem cells, which is why the D+Q combination is used together.
Navitoclax is the one with a real human track record, though not for aging. As a BCL-2 family inhibitor acting through BCL-2 and BCL-xL, it has been studied in preclinical models of diabetic retinopathy, idiopathic pulmonary fibrosis and osteoarthritis — where clearing dysfunctional chondrocytes promotes an anabolic phenotype — and has shown effectiveness in cancer treatment across chronic lymphocytic leukaemia, non-Hodgkin lymphoma, small cell lung cancer, adult T-cell leukaemia/lymphoma and head and neck squamous cell carcinoma.
The NAD+ story has cooled, and Dr. Lin reports it from the room. At a recent longevity physician conference she found substantially less enthusiasm for NR and NMN than before: much of the evidence is preclinical, some benefits have failed to replicate even in animals, and the human signal appears limited to people burning enormous amounts of energy — athletes, the very physically active — or those who are older and genuinely depleted. There was also discussion of reductive stress from excessive supplementation, the mirror image of oxidative stress, in which too many reducing agents disrupt normal cellular processes. She does not typically recommend NAD+ precursors to her patients unless they are specifically after performance and recovery.
Megadosing antioxidants can be actively harmful, which is the opposite of the marketing. High-dose beta-carotene has been linked to increased lung cancer risk in smokers, and high vitamin E to higher mortality. The mechanism is that reactive oxygen species are not purely damage — they serve cell signalling and programmed cell death — so flooding the system disrupts processes you need. Her recommendation is antioxidants from whole foods rather than high-dose supplements.
On omega-3s she is at her most confident, and specific: 1.25 to 2.5 grams daily is the standard anti-aging range, with the higher end producing more pronounced effects including reduced cortisol and IL-6. The mechanisms she cites are increased beta-oxidation and ATP production, enhanced superoxide dismutase and catalase activity, and telomere maintenance. Through food that means roughly 3 to 6 ounces of fatty fish — and flax and chia require around ten times the amount because the conversion is inefficient. She takes more than standard herself given her family's heart disease history, in liquid form.
Her reframe of the metabolism question is the most practically useful part of the listener Q&A. Foods that 'speed up metabolism' — caffeine chief among them — deliver a couple of percent, temporarily, and rarely last. What matters more is the food matrix: fibrous foods cost energy to digest and leave you feeling differently than the same calories in a sugary drink. She also pushes back on resting metabolic rate testing as falsely precise, since anxiety, talking or reading during the test shifts the result. Her counting targets are 30g of fibre daily, roughly 30g of protein per main meal, and 0.7 to 1 gram of protein per pound of body weight per day.

Chapters

00:00

Beyond pills: lifestyle foundations that still matter

Questions

Can aging actually be reversed?

In cells, in laboratories, partially — yes, and that is genuinely established. Cellular reprogramming using the Yamanaka factors has reset the epigenetic clock, reduced inflammation and restored regenerative capacity in aged human cells, and partial intermittent reprogramming has extended lifespan in mice engineered to age prematurely. But Dr. Lin is clear this is far from practical human use. She is stricter still about lifestyle: she will say lifestyle slows aging and reverses specific damage — a dyslipidemic lipid panel, an elevated hs-CRP — but explicitly declines to say lifestyle reverses aging itself, because she does not believe the evidence supports that claim. The honest summary is that the science is real, most of what is marketed on the back of it is hype, and the field cannot yet fully answer the question because it lacks a measurement everyone trusts.

How is biological age measured, and are the commercial tests any good?

Several ways, none settled. Epigenetic clocks read DNA methylation patterns — the first, Steve Horvath's in 2013, was a field-defining milestone, and current versions are machine-learning algorithms rather than formulas. Others use telomere length, glycan-based inflammation measures, or routine blood biomarkers. Newer approaches such as Generation Lab's quantify 'biological noise' — the increasing variability in gene expression across cells with age, evidenced by single-cell RNA sequencing in tissues like pancreas and muscle stem cells. Dr. Lin states she has no affiliation with any of these companies and that her honest position is that no single test is especially good yet. That matters beyond curiosity: without a trustworthy measure, there is no way to tell whether an anti-aging intervention is working.

Do senolytics like dasatinib and quercetin work?

The mechanism is well-characterised: senescent cells accumulate with age, resist normal cell death, and secrete inflammatory signals that damage surrounding tissue — senolytics selectively trigger apoptosis in them by disabling the anti-apoptotic pathways keeping them alive. Dasatinib is particularly effective against human preadipocytes, quercetin against senescent endothelial cells and mesenchymal stem cells, which is why they are combined. But Dr. Lin is unambiguous that this remains preclinical: the cardiac function and exercise capacity improvements are mouse results, and while the combination is popular in longevity practice and some clinicians already use it, she says it is not ready for prime time. Fisetin, found in strawberries, apples, persimmons and onions, has the same status. Navitoclax is the exception with substantial human data, but that data comes from cancer treatment, not aging.

Are NAD+ supplements like NMN and NR worth taking?

Dr. Lin's position has become more sceptical, and she attributes that partly to what she heard at a recent longevity physician conference where enthusiasm was noticeably lower than before. The evidence is mostly preclinical, some findings have failed to replicate even in animal models, and human clinical evidence remains very limited — though early studies do show NAD+ levels can be safely raised, with signals on lipid profiles, blood pressure and inflammation. Where benefit does appear, it seems concentrated in people expending enormous energy, such as athletes and the very physically active, or those who are older and genuinely depleted. There is also an emerging concern about reductive stress from excessive supplementation — the mirror of oxidative stress, where too many reducing agents disrupt normal cellular processes. She does not typically recommend these to her patients unless they are specifically after performance and recovery benefits.

Is collagen supplementation actually useful, or is protein enough?

The evidence for collagen improving skin aging or joint function is mixed, and the mechanistic objection is legitimate: your body breaks collagen down into amino acids just as it does any other protein, then uses them as needed. Dr. Lin's honest defence of it is about tolerability rather than biology. Collagen supplements are essentially pre-digested, which makes them easier to break down than a large load of animal protein or a protein shake — something she experienced herself during a period of trying to build muscle, where high protein intake left her uncomfortably full for too long. Her conclusion is that you do not need it and a balanced diet is just as effective, but that it is a reasonable convenience for some people. She drinks a cup of bone broth most mornings, with 5g of creatine stirred in.

Does green tea help kidney function?

There is more here than Dr. Lin initially expected — she flagged it as under-studied mid-episode and then came back to it. Studies show green tea can help prevent progression of diabetic nephropathy, and interestingly the benefit appears to operate independently of glycemic control, which is notable given that high blood sugar is itself what damages the kidneys. The proposed mechanisms are green tea polyphenols mitigating inflammation and fibrosis, and an increase in soluble RAGE, which is protective against damage from advanced glycation end products. One to two cups is well within a reasonable range and carries far less caffeine than coffee — worth noting because excessive caffeine can dehydrate you enough to worsen kidney function, and Dr. Lin is a slow caffeine metaboliser herself. Her one caveat is sourcing: the best tea comes from Asia, where pesticide use is often heavy, and she notes reports of acute illness from pesticide exposure alone.

The Longevity Letter